Benuvia Revenue
Pharmaceutical Manufacturing • 
3950 N Mays St, Round Rock, United States • 21-50 Employees
Benuvia revenue & valuation
| Annual revenue | $15,000,000 |
| Revenue per employee | $385,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $48,000,000 |
| Total funding | No funding |
Key Contacts at Benuvia
Terry Novak
Chief Executive Officer
Gina Amaya
Director Of Human Resources
Paul Zogala
Director
Joe Giraudo
Director Commercial Operations
Godfrey Awuah-Mensah
Director Of Manufacturing
Patrick Woydziak
Director Facilities Engineering
Company overview
| Headquarters | 3950 N Mays St, Round Rock, Texas 78665, US |
| Phone number | +17377874313 |
| Website | |
| NAICS | 3254 |
| SIC | 804 |
| Keywords | Controlled Substances, Analytical Development, Regulatory Services, Cannabinoids, Pharmaceutical Development, CBC, Analytical Testing, Psychedelics, Api Manufacturing, CBG, Liquid Fill, D9Thc |
| Founded | 2020 |
| Employees | 21-50 |
| Socials |
Benuvia Email Formats
Benuvia uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@benuvia.com), used 61.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@benuvia.com | 61.5% |
{first name}{last name} | johndoe@benuvia.com | 38.5% |
About Benuvia
At Benuvia, we help clients navigate the complexities of the development and manufacture of controlled substances for novel therapies, offering complete control over the drug development process. As a specialized CDMO offering small molecule API and finished dose development and cGMP manufacturing services, we specialize in the formulation, synthesis, and production of highly regulated and complex compounds, delivering end-to-end solutions tailored to our clients’ needs. We provide the expertise, process optimization, scale-up capabilities, and infrastructure to accelerate time-to-market while also reducing costs. Benuvia is a pioneer in the development and manufacturing of controlled substances with over 15 years of experience in cannabinoids, psychedelics, and other highly regulated compounds. We are the go-to partner for companies seeking high-quality products, robust regulatory compliance, and a first-class customer experience. Benuvia has been at the forefront of cannabinoid innovation since 2009, manufacturing pharmaceutical-grade, cGMP pure cannabidiol (CBD). Our expertise extends to other highly controlled substances, allowing us to support therapies in emerging fields like psychedelics. From formulation to API synthesis and robust analytical development to manufacturing, packaging, serialized labeling, warehousing, import and export capabilities, and regulatory affairs, Benuvia offers a comprehensive suite of solutions to meet your clinical and commercial goals. Located near Austin, TX, in Round Rock, our 83,000-square-foot, purpose built, state-of-the-art facility is DEA and FDA registered and fully compliant with cGMP standards, as well as the DEA, EPA, and OSHA. These certifications, along with our proven track record in controlled substances, ensure the highest levels of quality, safety, and compliance for your products. Benuvia helps you navigate the unique challenges of controlled substances with tailored global solutions. Reach out today.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Benuvia has 18 employees across 5 departments.
Departments
Number of employees
Funding Data
Benuvia has never raised funding before.
Benuvia Tech Stack
Discover the technologies and tools that power Benuvia's digital infrastructure, from frameworks to analytics platforms.
Security
Security
WordPress themes
Form builders
Analytics
JavaScript libraries
JavaScript libraries
Page builders
JavaScript libraries
CDN
Analytics
United Kingdom
India
Germany
Frequently asked questions
4.8
40,000 users
